Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients

Fig. 2

Late injury pattern in the lung tissue. Pronounced phenomena of the organization. Fixation: 10% neutral formalin. Technique: staining with hematoxylin and eosin (A, B) and picro Mallory (C) and PCNA was detected using immunolabeling with primary rabbit monoclonal antibodies Anti-PCNA antibody (Epitomics #AC-0087RUO, clone EP91, dilution 1:1000, USA), (D). A A late stage diffuse alveolar damage; the walls of the alveoli are thickened, hemorrhages and desquamation of the alveolar epithelium are observed, the focus of inflammatory infiltration is represented by lymphocytes. B A late stage diffuse alveolar damage; pronounced fibrosis of the alveolar septa, desquamation of the alveolar epithelium. C A late stage diffuse alveolar damage; special staining reveals the connective tissue fibers (blue color), focal hemorrhages, desquamation of the alveolar epithelium. D Expression of PCNA in type II alveolocytes (brown staining). Scale bars AC—100 μm, D—50 μm

Back to article page